Literature DB >> 15470335

QT interval prolongation after oxytocin bolus during surgical induced abortion.

Beny Charbit1, Christian Funck-Brentano, Emmanuel Samain, Virginie Jannier-Guillou, Pierre Albaladejo, Jean Marty.   

Abstract

BACKGROUND: Although oxytocin, a uterotonic agent, may cause short-term vasodilation that results in severe hypotension, it is still routinely given as an intravenous bolus injection during surgical suction curettage. Two reported cases of ventricular tachycardia after oxytocin bolus in patients with long QT interval syndrome led us to assess the effect of oxytocin on QT interval.
METHOD: Thirty-eight healthy women scheduled for a surgical suction curettage with general anesthesia were enrolled. General anesthesia was induced by propofol and maintained by either propofol (n = 18) or sevoflurane (n = 20). Electrocardiographic recordings were obtained before and at 1, 2, 3, and 5 minutes after a 10-U intravenous bolus of oxytocin.
RESULTS: Intravenous oxytocin induced a pronounced QTc interval prolongation of 41 +/- 21 ms ( P < .0001), which was maximal 1 minute after administration. The QTc interval returned to control values 3 minutes after oxytocin bolus. Oxytocin bolus also induced an increase in heart rate of 19 +/- 10 beats/min and a significant decrease in systolic arterial pressure of 11 +/- 9 mm Hg (both P < .0001). The drug used to maintain anesthesia was not an independent factor of QT interval prolongation in ANOVA analysis.
CONCLUSIONS: Oxytocin intravenous bolus induced a large and transient QTc interval prolongation, suggesting that it may lead to proarrhythmia in circumstances favoring QTc interval increase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15470335     DOI: 10.1016/j.clpt.2004.06.005

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

Review 1.  Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Preclinical toxicity screening of intrathecal oxytocin in rats and dogs.

Authors:  Tony L Yaksh; Shotaro Hobo; Christopher Peters; Kent G Osborn; Philip J Richter; Steven S Rossi; Marjorie R Grafe; James C Eisenach
Journal:  Anesthesiology       Date:  2014-04       Impact factor: 7.892

3.  Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour.

Authors:  Olufemi T Oladapo; Babasola O Okusanya; Edgardo Abalos; Ioannis D Gallos; Argyro Papadopoulou
Journal:  Cochrane Database Syst Rev       Date:  2020-11-09

4.  Phase 1 safety assessment of intrathecal oxytocin.

Authors:  James C Eisenach; Chuanyao Tong; Regina Curry
Journal:  Anesthesiology       Date:  2015-02       Impact factor: 8.986

5.  Oxytocin does not directly alter cardiac repolarization in rabbit or human cardiac myocytes.

Authors:  Yusheng Qu; Mei Fang; BaoXi Gao; Shanti Amagasu; William J Crumb; Hugo M Vargas
Journal:  Pharmacol Res Perspect       Date:  2014-12-09

6.  Effect of different doses of oxytocin on cardiac electrophysiology and arrhythmias induced by ischemia.

Authors:  Fariba Houshmand; Mahdieh Faghihi; Alireza Imani; Soleiman Kheiri
Journal:  J Adv Pharm Technol Res       Date:  2017 Oct-Dec

7.  Successful vaginal delivery in a parturient with long QT syndrome type 2 using double-catheter epidural analgesia: A CARE-compliant case report.

Authors:  Hironori Ishizaki; Hiroaki Murata; Takuji Maekawa; Taiga Ichinomiya; Tetsuya Hara
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

8.  Oxytocin exerts harmful cardiac repolarization prolonging effects in drug-induced LQTS.

Authors:  Paul Kreifels; Ilona Bodi; Tibor Hornyik; Gerlind Franke; Stefanie Perez-Feliz; R Lewetag; Robin Moss; Alessandro Castiglione; David Ziupa; Manfred Zehender; Michael Brunner; Christoph Bode; Katja E Odening
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-03

Review 9.  Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour.

Authors:  Olufemi T Oladapo; Babasola O Okusanya; Edgardo Abalos
Journal:  Cochrane Database Syst Rev       Date:  2018-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.